State Street® SPDR® S&P® Biotech ETF announces dividend of $0.4066
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 22 2025
0mins
Source: SeekingAlpha
Dividend Declaration: State Street® SPDR® S&P® Biotech ETF (XBI) has declared a quarterly dividend of $0.4066 per share, payable on December 24 to shareholders of record on December 22, with an ex-dividend date also on December 22.
Biotech Market Insights: The article discusses the potential overdue recovery in biotech funding conditions and highlights the speculative nature of the XBI ETF, which is designed to amplify exposure to the biotech sector.
Analyst Views on XBI
Wall Street analysts forecast XBI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for XBI is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 128.180
Low
Averages
High
Current: 128.180
Low
Averages
High
No data
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
